RPE65 and Leber congenital amaurosis: Similarly, multifunctional lipid nanoparticles modified with all‐trans‐retinamine have been shown to deliver plasmid DNA to the retina in the Rpe65−/− mouse model for the treatment of Leber's congenital amaurosis caused by RPE65 gene mutations [106].